Liron Carmel - MDGS Old Chief Officer
MDGSDelisted Stock | USD 1.73 0.01 0.58% |
Executive
Mr. Liron Carmel is Chief Executive Officer of the company. Mr. Carmel serves as Chief Executive Officer and director of CannaPowder, a biopharma company dedicated to developing and applying innovative technology in the cannabinoid field. Mr. Carmel also serves as a director of Chiron Refineries Ltd., a company engaged in consulting and initiation of transactions in the refineries field. In addition he serves as chairman of the Israel Tennis Table Association. He also served as vice president business development at Yaad Givatayim development, a municipal corporation dedicated to initiate, develop and establish projects of public importance. Prior to Yaad Givatayim, Mr. Carmel served as an investment manager and as a research and strategy analyst at Excellence Nessuah, one of the leading companies in the field of provident and advanced studies funds in Israel. since 2019.
Age | 39 |
Tenure | 6 years |
Phone | 972 73 370 4691 |
Web | https://www.medigus.com |
MDGS Old Management Efficiency
The company has return on total asset (ROA) of (0.0663) % which means that it has lost $0.0663 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3072) %, meaning that it created substantial loss on money invested by shareholders. MDGS Old's management efficiency ratios could be used to measure how well MDGS Old manages its routine affairs as well as how well it operates its assets and liabilities.MDGS Old currently holds 10.13 M in liabilities with Debt to Equity (D/E) ratio of 0.27, which may suggest the company is not taking enough advantage from borrowing. MDGS Old has a current ratio of 1.35, which is within standard range for the sector. Note, when we think about MDGS Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | EXECUTIVE Age | ||
FACC MD | Nuwellis | N/A | |
Hans Kestler | Paragon 28 | N/A | |
Richard MD | Brainsway | N/A | |
Hadar Levy | Brainsway | 51 | |
Carolyn Shelton | Nexalin Technology | 63 | |
Matthew Brinckman | Paragon 28 | N/A | |
Hillegonda Groen | Brainsway | 56 | |
Matthew Jarboe | Paragon 28 | 42 | |
Jonathan Friedman | Paragon 28 | 53 | |
Thomas Stankovich | ReShape Lifesciences | 64 | |
Ido Marom | Brainsway | 49 | |
Stephen Deitsch | Paragon 28 | 52 | |
Jay Sturm | STRATA Skin Sciences | 69 | |
Matthew Millard | Paragon 28 | N/A | |
Andrew Hill | Paragon 28 | 41 | |
Shmuel Gov | STRATA Skin Sciences | 65 | |
David Hoffman | Delcath Systems | N/A | |
Merav Dotan | Icecure Medical | 56 | |
Monica Hamling | Nortech Systems Incorporated | N/A | |
Les DeLuca | Bluejay Diagnostics | N/A | |
John Manders | SurModics | 43 |
Management Performance
Return On Equity | -0.31 | |||
Return On Asset | -0.0663 |
MDGS Old Leadership Team
Elected by the shareholders, the MDGS Old's board of directors comprises two types of representatives: MDGS Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MDGS. The board's role is to monitor MDGS Old's management team and ensure that shareholders' interests are well served. MDGS Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MDGS Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ilan Oren, Executive Officer | ||
Yaron Silberman, Chief Ltd | ||
Liron Carmel, Chief Officer | ||
Tali Dinar, Chief Officer |
MDGS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MDGS Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.31 | |||
Return On Asset | -0.0663 | |||
Profit Margin | (0.13) % | |||
Operating Margin | (0.09) % | |||
Current Valuation | 65.3 M | |||
Shares Outstanding | 1.89 M | |||
Shares Owned By Institutions | 0.29 % | |||
Number Of Shares Shorted | 4.18 K | |||
Price To Earning | 33.86 X | |||
Price To Book | 0.15 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in MDGS Stock
If you are still planning to invest in MDGS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MDGS Old's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |